190 related articles for article (PubMed ID: 16464590)
1. Radanamycin, a macrocyclic chimera of radicicol and geldanamycin.
Wang M; Shen G; Blagg BS
Bioorg Med Chem Lett; 2006 May; 16(9):2459-62. PubMed ID: 16464590
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
Clevenger RC; Blagg BS
Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
[TBL] [Abstract][Full Text] [Related]
3. Radester, a novel inhibitor of the Hsp90 protein folding machinery.
Shen G; Blagg BS
Org Lett; 2005 May; 7(11):2157-60. PubMed ID: 15901158
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
6. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
Hadden MK; Lubbers DJ; Blagg BS
Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
[TBL] [Abstract][Full Text] [Related]
9. Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90.
Kitson RR; Moody CJ
J Org Chem; 2013 Jun; 78(11):5117-41. PubMed ID: 23496136
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
[TBL] [Abstract][Full Text] [Related]
11. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K
Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
Hadden MK; Blagg BS
J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.
Gadelle D; Bocs C; Graille M; Forterre P
Nucleic Acids Res; 2005; 33(7):2310-7. PubMed ID: 15849317
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
Zapf CW; Bloom JD; McBean JL; Dushin RG; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Levin JI
Bioorg Med Chem Lett; 2011 Jun; 21(12):3627-31. PubMed ID: 21605975
[TBL] [Abstract][Full Text] [Related]
15. hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90.
Billecke SS; Bender AT; Kanelakis KC; Murphy PJ; Lowe ER; Kamada Y; Pratt WB; Osawa Y
J Biol Chem; 2002 Jun; 277(23):20504-9. PubMed ID: 11923316
[TBL] [Abstract][Full Text] [Related]
16. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors.
Suda A; Koyano H; Hayase T; Hada K; Kawasaki K; Komiyama S; Hasegawa K; Fukami TA; Sato S; Miura T; Ono N; Yamazaki T; Saitoh R; Shimma N; Shiratori Y; Tsukuda T
Bioorg Med Chem Lett; 2012 Jan; 22(2):1136-41. PubMed ID: 22192591
[TBL] [Abstract][Full Text] [Related]
18. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.
Shen Y; Xie Q; Norberg M; Sausville E; Vande Woude G; Wenkert D
Bioorg Med Chem; 2005 Aug; 13(16):4960-71. PubMed ID: 15978816
[TBL] [Abstract][Full Text] [Related]
20. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin].
Liao ZY; Zhen YS
Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116
[No Abstract] [Full Text] [Related]
[Next] [New Search]
